Rossari Biotech plans to boost performance through increased production and a new push into Saudi Arabia. Investors are tracking the company's efforts to turn its cleaning business profitable and lower its debt of ₹240 crore.
Rossari Biotech aims to accelerate its business performance in the coming quarters by leveraging recently commissioned manufacturing facilities and entering new international markets. The specialty chemical company, which recently reported its April-June 2026 financial results, stated that its production units are nearing full usage levels, which is expected to support future revenue growth.
Strategic Expansion and International Focus
To streamline its global operations, the company is consolidating its international subsidiaries under a new holding entity based in Singapore. A key part of its growth strategy involves expanding its footprint in Saudi Arabia. While the company has not provided specific financial targets for the 2027 fiscal year, it continues to focus on its core areas, including textile specialty chemicals, biosurfactants, and home and personal care products. The company recently received REACH approval for its biosurfactants, a certification that allows for easier trade and compliance within European markets.
Financial Health and Debt Management
Rossari Biotech is currently managing a total debt of approximately ₹240 crore. As part of its capital management plan, the company intends to sell non-core assets to reduce its borrowings. Management has set a goal to keep its debt-to-EBITDA ratio below 2x. Additionally, the company is working on its working capital cycle by focusing on faster inventory turnover and reducing the time taken to collect payments from customers. This shift is intended to improve cash flow and strengthen the balance sheet.
Segment Performance and Future Outlook
The home and personal care segment remains a critical part of the company's long-term plan, with expectations that it will form about 90% of the total business within five years. However, not all divisions are performing equally. The company's institutional cleaning and hygiene segment reported an EBITDA loss in the most recent quarter. Management is aiming to turn this specific division profitable by the end of the 2026 fiscal year. Investors will likely monitor the company’s ability to execute its expansion plans without overextending its finances and whether it can successfully return its cleaning and hygiene segment to profitability as planned.